Old Mission Capital’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Old Mission Capital’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,319	Closed	-$8.04K	–	1830
2022 Q4	$8.04K	Buy	+16,319	New	+$16.5K	﹤0.01%	1284
2021 Q3	–	Sell	-11,323	Closed	-$60K	–	1368
2021 Q2	$60K	Buy	+11,323	New	+$67.7K	﹤0.01%	986
2016 Q1	–	Sell	-9,776	Closed	-$534K	–	342
2015 Q4	$534K	Buy	+9,776	New	+$431K	0.07%	165

Other funds holding CYAD

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Old Mission Capital's CYAD Position: Q1 2023 in Review

Old Mission Capital sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q1 2023, closing a stake of 16,319 shares — an estimated $8.04K sold.

Old Mission Capital first reported a position in CYAD in Q4 2015 and held it in 3 quarters. The position peaked at $534K in Q4 2015. 8 funds tracked by Wall St. Rank hold CYAD as of Q1 2023.

Old Mission Capital reported no remaining Celyad Oncology SA American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Old Mission Capital sold 16,319 Celyad Oncology SA American Depositary Shares shares in Q1 2023, an estimated $8.04K.
Old Mission Capital first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2015 and held it in 3 quarters.
Old Mission Capital's Celyad Oncology SA American Depositary Shares position peaked at $534K in Q4 2015.
8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.